πŸš€ Pharmidex at OBN Science Social – Join Us! πŸ”¬
February 12, 2025

We’re excited to announce that Ash Alavijeh, our Head of Operations, will be attending the OBN Science Social in Stratford, London!


Today πŸ•• Time: 18:00 - 20:00

πŸ“ Location: Cancer Research Horizons, 2 Redman Place, London E20 1JQ

(https://lnkd.in/eQuhhzph)


Ash looks forward to meeting fellow attendees, engaging in insightful discussions, and exploring new opportunities for collaboration. 


At Pharmidex, we are passionate about enhancing capabilities in drug discovery and development, and we’re always keen to connect with like-minded professionals.


If you're attending, don’t hesitate to say hello and have a chat! Looking forward to an evening of networking and innovation.

#Pharmidex #OBNScienceSocial #DrugDiscovery #Collaboration #Networking #PharmaInnovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. πŸ‘©‍πŸ”¬ πŸ‘¨‍πŸ”¬ Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: βœ… Bitter-tasting APIs βœ… Unpalatable excipients βœ… The success of taste-masking strategies βœ… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts